Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Keiko Ohata"'
Autor:
Masamichi Takahashi, Satoshi Kawashima, Yohei Otake, Natsuko Satomi-Tsushita, Aya Kuchiba, Ryo Sadachi, Keiko Ohata, Hitoshi Ozawa, Kan Yonemori, Motoo Nagane, Yoshiki Arakawa, Akitake Mukasa, Shota Tanaka, Ryo Nishikawa, Yoshihiro Muragaki, Kenkichi Masutomi, Koichi Ichimura, Kenichi Nakamura, Yoshitaka Narita
Publikováno v:
Journal of Clinical Oncology. 40:2036-2036
2036 Background: Glioblastoma (GBM) is one of the worst prognostic cancers and there is no effective treatment after failure of bevacizumab. Eribulin is a microtubule inhibitor used for the treatment of patients with metastatic breast cancer and lipo
Autor:
Daisuke Nakai, Satoshi Matsui, Yoko Nagai, Satoru Naito, Akira Nakao, Kiyoshi Oizumi, Tsuyoshi Shinozuka, Kousei Shimada, Kazuki Yano, Keiko Ohata, Keiji Saito
Publikováno v:
Bioorganic & Medicinal Chemistry. 21:1628-1642
A cell-based assay was performed for the discovery of novel bone anabolic agents. Alkaline phosphatase (ALPase) activity of ST2 cells was utilized as an indicator of osteoblastic differentiation, and thienopyridine derivative 1 was identified as a hi
Autor:
Keiko Ohata, Tomoko Niki-Kuroiwa, Jun-ichi Takeuchi, Satoru Suzuki, Marek Banasik, Norio Ishida, Koichiro Kako, Hisanori Wakamatsu, Toshiyuki Hamada
Publikováno v:
Brain research. Brain research protocols. 2(4)
Electrophoretical mobility shift assay (EMSA) is a simple, rapid, and highly sensitive technique for detection of single- or double-stranded DNA-binding proteins such as transcription factors in crude nuclear extracts (F.M. Ausubel, R. Brent, R.E. Ki